[GOAL] The GOAL mailing list

Wed Sep 8 14:52:08 BST 2021

I found the discussion on IP interesting, but the main advantage of such
a distribution list over Twitter is its higher signal to noise ratio
(SNR). Next to the better ability to express oneself without character
limits.

When a discussion moves off topic, I would not be too strict, but when
it already starts off topic it may be good to think of the SNR.

For me the GOAL list is a useful resource for information to put on the
Open Science Feed. So I hope it continues.
https://reddit.com/r/Open_Science/

On 03/09/2021 21:15, Richard Poynder wrote:
> “GOAL may or may not be the right venue for this discussion. Advice on
> this would be welcome.”
> 
>  
> 
>>>>> 
> 
>  
> 
> On this question, on the role of GOAL, and on the future of the list I
> am happy to hear the views of list members.
> 
>  
> 
> I have been thinking about the future of GOAL for a while now. As the
> name signals, it was set up to discuss open access. More specifically,
> the description of the list says that it is “dedicated to the discussion
> of Open Access practice and policy-making by the worldwide research
> community (in no order: researchers, universities, research
> institutions, research funding agencies, governmental research
> policy-makers and commercial entities) with the aim of enabling
> concrete, practical steps to be taken to achieve Open Access. Chief
> among these goals are techniques for increasing the amount of Open
> Access, as well as metrics of research usage and impact.”
> 
>  
> 
> However, discussions about open access have now become mainstream and
> the reality is that much of the debate tends to take place elsewhere
> today, not least on Twitter.
> 
>  
> 
> I am happy to continue moderating the list, I am happy for the list to
> continue as it is. I am also happy to discuss GOAL’s focus, its role and
> its future. But I think this would need to be a discussion that members
> of the list were involved in.
> 
>  
> 
> All thoughts/suggestions are welcomed.
> 
>  
> 
> Best wishes,
> 
>  
> 
>  
> 
> Richard Poynder
> 
> GOAL Moderator
> 
>  
> 
>  
> 
> *From:*goal-bounces at eprints.org <goal-bounces at eprints.org> *On Behalf Of
> *Heather Morrison
> *Sent:* 03 September 2021 16:14
> *To:* Global Open Access List (Successor of AmSci) <goal at eprints.org>
> *Subject:* Re: [GOAL] COVID IP waiver request: interesting but not
> entirely informed?
> 
>  
> 
> Thank you, Ulrich. 
> 
>  
> 
> The exception does look like it would be helpful in an emergency like
> COVID, and likely necessary as the default is an expectation of
> protection of rights and commercial exploitation; this is also on p. 102.
> 
>  
> 
> There is a sharp contrast in the E.U. and North America between success
> in achieving OA as the default in dissemination of results and
> expectation of protecting IP for commercial exploitation. It would be
> interesting to have meaningful and informed discussion about this. To
> participate in informed discussion, participants should understand the
> basics about the different types of IP. For those who may be new to this
> area, WIPO's "What is intellectual property" page is a good starting point: 
> 
> https://www.wipo.int/about-ip/en/ <https://www.wipo.int/about-ip/en/>
> 
>  
> 
> The Public Library of Science (PLOS) Terms of Use may also be helpful to
> OA advocates in understanding the different types of IP. Like most fully
> OA publishers with a firm commitment to open licensing, PLOS is very
> protective of their own work, including their own text on the website
> and their trademark. 
> 
> https://www.wipo.int/about-ip/en/
> <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.wipo.int%2Fabout-ip%2Fen%2F&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109834028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=Hz1za3hvUkRVKMxVVUOh0L9Y9y1eTHr%2B0HfIkb8wrrw%3D&reserved=0>
> 
>  
> 
> The Google business model of advertising-supported facilitated access to
> free knowledge and services created by others, made possible by
> algorithms carefully protected as trade secrets, is another example of
> how different the various types of IP are. It is not unusual for a
> single internet search to invoke multiple different types of IP that
> work in very different fashion. 
> 
>  
> 
> COVID is an interesting case study. My impression (not based on
> substantive research) is that the world, including the traditional
> commercial scholarly publishing industry, has made considerable progress
> in open sharing of information about the virus. There is no doubt still
> a great deal of room for improvement, but this is an advance and should
> be celebrated as much. I wonder how much the success of the OA / open
> data movements to date contributed to the rapid development of COVID
> vaccines in multiple countries. 
> 
>  
> 
> Manufacturing involves patent law, and the manufacturing industries are
> very different from scholarly publishing. In the case of COVID vaccine
> manufacture, even under the current licensing regime, we have instances
> of what looks to me (as a non-expert) like rapid implementation of
> manufacture (Johnson & Johnson in Baltimore, more recently a Moderna
> factory in Spain creating doses for Japan) resulting in contaminated
> vaccines. This is not helpful in a context where vaccine hesitancy and
> an anti-vaccination movement are significant barriers to addressing
> COVID. In this case, simply opening up the rights to manufacture
> vaccines to anyone could do more harm than good.
> 
>  
> 
> On the other hand, the profit-driven pharma-as-usual model may be
> driving a push for booster shots in rich countries that may not be
> necessary, when the most compassionate and smartest approach (even for
> the rich countries) is likely shots in arms everywhere (to reduce
> opportunities for new variants to develop). I see this as a good
> opportunity for discussion on how IP works in this area and how to do it
> better. Lessons from the OA movement may or may not be relevant, but
> understanding how to produce and distribute quality vaccines and other
> medicines is absolutely essential for informed discussion in this area. 
> 
>  
> 
> GOAL may or may not be the right venue for this discussion. Advice on
> this would be welcome. 
> 
>  
> 
> best,
> 
>  
> 
> Dr. Heather Morrison
> 
> Associate Professor, School of Information Studies, University of Ottawa
> 
> Cross-appointed, Department of Communication
> 
> Professeur Agrégé, École des Sciences de l'Information, Université d'Ottawa
> 
> Principal Investigator, Sustaining the Knowledge Commons, a SSHRC
> Insight Project
> 
> sustainingknowledgecommons.org
> 
> Heather.Morrison at uottawa.ca <mailto:Heather.Morrison at uottawa.ca>
> 
> https://uniweb.uottawa.ca/?lang=en#/members/706
> <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Funiweb.uottawa.ca%2F%3Flang%3Den%23%2Fmembers%2F706&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109834028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=tPGz85O764Yv%2FlxZZOMDPOTxjSJuZqYFtJx%2FEgUtbd0%3D&reserved=0>
> 
>  
> 
> ------------------------------------------------------------------------
> 
> *From:*Ulrich Herb <u.herb at sulb.uni-saarland.de
> <mailto:u.herb at sulb.uni-saarland.de>>
> *Sent:* Friday, September 3, 2021 7:36 AM
> *To:* goal <goal at eprints.org <mailto:goal at eprints.org>>
> *Cc:* Heather Morrison <Heather.Morrison at uottawa.ca
> <mailto:Heather.Morrison at uottawa.ca>>
> *Subject:* Re: [GOAL] COVID IP waiver request: interesting but not
> entirely informed?
> 
>  
> 
> Attention : courriel externe | external email
> 
> perhaps this might be of interest: in its new research framework
> programme Horizon Europe the European Commission states this
> (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf
> <https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf>,
> p. 102) ...
> ***
> Where the call conditions impose additional exploitation obligations in
> case of a public
> emergency, the beneficiaries must (if requested by the granting
> authority) grant for a limited
> period of time specified in the request, non-exclusive licences — under
> fair and reasonable
> conditions — to their results to legal entities that need the results to
> address the public
> emergency and commit to rapidly and broadly exploit the resulting
> products and services at
> fair and reasonable conditions. This provision applies up to four years
> after the end of the
> action.
> ***
> 
> As there was no such statement in the model grant agreements of earlier
> framework programmes, I interpret this regulation a direct reaction to
> the COVID pandemic...
> 
> 
> Best regards
> 
> Ulrich
> 
> ----- Am 2. Sep 2021 um 22:07 schrieb Federico Leva (Nemo)
> nemowiki at gmail.com <mailto:nemowiki at gmail.com>:
> 
> Il 01/09/21 23:25, Heather Morrison ha scritto:
>> The WHO letter mentions but does not request what I suggest is a more
> likely approach to avoiding IP interference with addressing the pandemic
> in the short term: compulsory licensing.
> 
> This is the official reason used by the EU to block the waiver (or at
> least it was until Biden came out in support of it and force everyone to
> change tune).
> https://www.keionline.org/36300
> <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.keionline.org%2F36300&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109834028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=CbuQ5jo0tThbTcZzFWUZrhIvAp01tUxnMUJV3MwrchM%3D&reserved=0>
> 
> It's true that the USA could easily implement compulsory licensing
> overnight, but for other countries it can prove more difficult. There
> are dozens of articles in the KEI website on this matter, I'm unable to
> summarise them. It's highly recommended reading.
> 
> Communia, Wikimedia and others have also supported the extension of
> waiver to copyright, see most recently:
> https://www.communia-association.org/2021/03/22/communia-supports-the-wto-trips-waiver-for-covid-19/
> <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.communia-association.org%2F2021%2F03%2F22%2Fcommunia-supports-the-wto-trips-waiver-for-covid-19%2F&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109843985%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=COgxq9m0iE%2B9d5zL%2FDERmUuczfzB1fevEp0zMdNWPJk%3D&reserved=0>
> 
> Best regards,
>         Federico
> _______________________________________________
> GOAL mailing list
> GOAL at eprints.org <mailto:GOAL at eprints.org>
> http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
> <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fmailman.ecs.soton.ac.uk%2Fmailman%2Flistinfo%2Fgoal&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109843985%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=PXuwCDcLrGw3NooqmeL7M4%2FdLD77VFokLJsAYxMtDjQ%3D&reserved=0>
> --
> Mit freundlichen Grüßen
> 
> Dr. Ulrich Herb
> Saarländische Universitäts- und Landesbibliothek
> Referent für elektronisches Publizieren und Open Access,
> Drittmittel-Projekte
> 
> Postanschrift: Postfach 15 11 41 | 66041 Saarbrücken
> 
> Besucheranschrift:  Campus B1 1 | Raum 10.07. | 66123 Saarbrücken
> 
> T: +49 681 302-2798
> F: +49 681 302-2796
> u.herb at sulb.uni-saarland.de <mailto:u.herb at sulb.uni-saarland.de>
> www.sulb.uni-saarland.de
> <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.sulb.uni-saarland.de%2F&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109853942%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=0yF0B2y3HVhGanr4R0AWYrxbDrV2rSc8CqVNlylDJKw%3D&reserved=0>
> 
> 
> _______________________________________________
> GOAL mailing list
> GOAL at eprints.org
> http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
> 

-- 
<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>
Victor VENEMA
Grassroots Journals
https://grassroots.is

E-mail: Victor.Venema at grassroots.is
E-mail: Victor.Venema at protonmail.com
Homepage: http://www2.meteo.uni-bonn.de/victor
Blog: http://variable-variability.blogspot.com
Mastodon: https://fediscience.org/@VictorVenema
Twitter: https://twitter.com/VariabilityBlog
Matrix: @viv:datenburg.org
GIT: https://codeberg.org/Venema
GitHub: https://github.com/VictorVenema/

https://twitter.com/Grassr_Journals
https://fediscience.org/@OpenScienceFeed
https://twitter.com/OpenScienceR

There is no need to answer my mails in your free time.
<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>